Efficacy and safety of tafluprost 0.0015% – retrospective analysis of real-world data from the Philippines

PURPOSE: To investigate the IOP lowering effect and safety of tafluprost 0.0015% in a routine clinical setting in the Philippines. PATIENTS AND METHODS: A retrospective review of glaucoma patients receiving tafluprost 0.0015% (BAK 0.001% preserved) with a minimum follow-up of 3 months was conducted....

Descripción completa

Detalles Bibliográficos
Autores principales: Tumbocon, Joseph Anthony, Macasaet, Anne Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717730/
https://www.ncbi.nlm.nih.gov/pubmed/31695311
http://dx.doi.org/10.2147/OPTH.S209942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717730/
https://www.ncbi.nlm.nih.gov/pubmed/31695311
http://dx.doi.org/10.2147/OPTH.S209942

Ejemplares similares